Takaisin Tulosta

Eteisvärinä, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
22.3.2021

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Eteisvärinä «Eteisvärinä»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Abi-Mansour P, Carberry PA, McCowan RJ ym. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators. Am Heart J 1998;136:632-42 «PMID: 9778066»PubMed
  2. ACTIVE I Investigators., Yusuf S, Healey JS ym. Irbesartan in patients with atrial fibrillation. N Engl J Med 2011;364:928-38 «PMID: 21388310»PubMed
  3. ACTIVE Investigators., Connolly SJ, Pogue J ym. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009;360:2066-78 «PMID: 19336502»PubMed
  4. Albers GW. Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med 1994;154:1443-8 «PMID: 8017999»PubMed
  5. Alp NJ, Bell JA, Shahi M. Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation. Heart 2000;84:37-40 «PMID: 10862585»PubMed
  6. Anand K, Mooss AN, Hee TT ym. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. Am Heart J 2006;152:217-22 «PMID: 16875900»PubMed
  7. Andersen HR, Nielsen JC, Thomsen PE ym. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-6 «PMID: 9652562»PubMed
  8. Anderson JL, Gilbert EM, Alpert BL ym. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. Circulation 1989;80:1557-70 «PMID: 2513143»PubMed
  9. Arnold AZ, Mick MJ, Mazurek RP ym. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992;19:851-5 «PMID: 1545081»PubMed
  10. Avgil Tsadok M, Jackevicius CA, Rahme E ym. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 2012;307:1952-8 «PMID: 22570463»PubMed
  11. Barranco F, Sanchez M, Rodriguez J ym. Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency. Intensive Care Med 1994;20:42-4 «PMID: 8163757»PubMed
  12. Benjamin EJ, Muntner P, Alonso A ym. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 2019;139:e56-e528 «PMID: 30700139»PubMed
  13. Bernard EO, Schmid ER, Schmidlin D ym. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. Crit Care Med 2003;31:1031-4 «PMID: 12682468»PubMed
  14. Bilato C, Corti MC, Baggio G ym. Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study). Am J Cardiol 2009;104:1092-7 «PMID: 19801031»PubMed
  15. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. Arch Intern Med 1996;156:409-16 «PMID: 8607726»PubMed
  16. Block PC, Burstein S, Casale PN ym. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv 2009;2:594-600 «PMID: 19628179»PubMed
  17. Boersma LV, Ince H, Kische S ym. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. Heart Rhythm 2017;14:1302-1308 «PMID: 28577840»PubMed
  18. Boersma LV, Schmidt B, Betts TR ym. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 2016;37:2465-74 «PMID: 26822918»PubMed
  19. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators., Singer DE, Hughes RA ym. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11 «PMID: 2233931»PubMed
  20. Boudonas G, Lefkos N, Efthymiadis AP ym. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. Acta Cardiol 1995;50:125-34 «PMID: 7610735»PubMed
  21. Brignole M, Gianfranchi L, Menozzi C ym. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation 1997;96:2617-24 «PMID: 9355902»PubMed
  22. Brignole M, Menozzi C, Gianfranchi L ym. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 1998;98:953-60 «PMID: 9737514»PubMed
  23. Brignole M, Pokushalov E, Pentimalli F ym. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. Eur Heart J 2018;39:3999-4008 «PMID: 30165479»PubMed
  24. Cairns JA. Stroke prevention in atrial fibrillation trial. Circulation 1991;84:933-5 «PMID: 1860238»PubMed
  25. Calkins H, Reynolds MR, Spector P ym. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009;2:349-61 «PMID: 19808490»PubMed
  26. Capucci A, Lenzi T, Boriani G ym. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992;70:69-72 «PMID: 1615873»PubMed
  27. Carlsson J, Miketic S, Windeler J ym. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003;41:1690-6 «PMID: 12767648»PubMed
  28. Channer KS, Birchall A, Steeds RP ym. A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation. Eur Heart J 2004;25:144-50 «PMID: 14720531»PubMed
  29. Chevalier P, Durand-Dubief A, Burri H ym. Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003;41:255-62 «PMID: 12535819»PubMed
  30. Chugh SS, Havmoeller R, Narayanan K ym. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837-47 «PMID: 24345399»PubMed
  31. Climent VE, Marin F, Mainar L ym. Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2004;27:368-72 «PMID: 15009866»PubMed
  32. Collins LJ, Silverman DI, Douglas PS ym. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation 1995;92:160-3 «PMID: 7600646»PubMed
  33. Connolly SJ, Camm AJ, Halperin JL ym. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011;365:2268-76 «PMID: 22082198»PubMed
  34. Connolly SJ, Eikelboom J, Joyner C ym. Apixaban in patients with atrial fibrillation. N Engl J Med 2011;364:806-17 «PMID: 21309657»PubMed
  35. Connolly SJ, Ezekowitz MD, Yusuf S ym. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51 «PMID: 19717844»PubMed
  36. Connolly SJ, Laupacis A, Gent M ym. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55 «PMID: 1856403»PubMed
  37. Corley SD, Epstein AE, DiMarco JP ym. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-13 «PMID: 15007003»PubMed
  38. Corrado G, Santarone M, Beretta S ym. Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: a single centre 8.5-year experience. Europace 2000;2:119-26 «PMID: 11225938»PubMed
  39. Crijns HJ, Tjeerdsma G, de Kam PJ ym. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000;21:1238-45 «PMID: 10924313»PubMed
  40. Crijns HJ, van Wijk LM, van Gilst WH ym. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. Eur Heart J 1988;9:634-8 «PMID: 3137061»PubMed
  41. Cronin P, Sneider MB, Kazerooni EA ym. MDCT of the left atrium and pulmonary veins in planning radiofrequency ablation for atrial fibrillation: a how-to guide. AJR Am J Roentgenol 2004;183:767-78 «PMID: 15333369»PubMed
  42. Currie CJ, Jones M, Goodfellow J ym. Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin. Heart 2006;92:196-200 «PMID: 15883133»PubMed
  43. De Simone A, De Pasquale M, De Matteis C ym. VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study). Eur Heart J 2003;24:1425-9 «PMID: 12909071»PubMed
  44. Donovan KD, Dobb GJ, Coombs LJ ym. Efficacy of flecainide for the reversion of acute onset atrial fibrillation. Am J Cardiol 1992;70:50A-54A; discussion 54A-55A «PMID: 1509999»PubMed
  45. Donovan KD, Dobb GJ, Coombs LJ ym. Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide. Am J Cardiol 1991;67:137-41 «PMID: 1898998»PubMed
  46. Doshi RN, Daoud EG, Fellows C ym. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-5 «PMID: 16302897»PubMed
  47. Ellenbogen KA, Stambler BS, Wood MA ym. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J Am Coll Cardiol 1996;28:130-6 «PMID: 8752805»PubMed
  48. Ezekowitz MD, Bridgers SL, James KE ym. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992;327:1406-12 «PMID: 1406859»PubMed
  49. Fang MC, Go AS, Chang Y ym. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 2007;120:700-5 «PMID: 17679129»PubMed
  50. Fang MC, Go AS, Hylek EM ym. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc 2006;54:1231-6 «PMID: 16913990»PubMed
  51. Ferreira AM, Adragão P, Cavaco DM ym. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. Europace 2008;10:809-15 «PMID: 18511438»PubMed
  52. Fetsch T, Bauer P, Engberding R ym. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 2004;25:1385-94 «PMID: 15302102»PubMed
  53. Flaker GC, Blackshear JL, McBride R ym. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 1992;20:527-32 «PMID: 1512329»PubMed
  54. Fung JW, Chan SK, Yeung LY ym. Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials. Eur J Heart Fail 2002;4:489-94 «PMID: 12167389»PubMed
  55. García-Fernández MA, Pérez-David E, Quiles J ym. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol 2003;42:1253-8 «PMID: 14522491»PubMed
  56. Gasparini M, Auricchio A, Regoli F ym. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006;48:734-43 «PMID: 16904542»PubMed
  57. Gasparini M, Leclercq C, Lunati M ym. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). JACC Heart Fail 2013;1:500-7 «PMID: 24622002»PubMed
  58. Gillis AM, Wyse DG, Connolly SJ ym. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999;99:2553-8 «PMID: 10330387»PubMed
  59. GISSI-AF Investigators., Disertori M, Latini R ym. Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med 2009;360:1606-17 «PMID: 19369667»PubMed
  60. Giugliano RP, Ruff CT, Braunwald E ym. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013;369:2093-104 «PMID: 24251359»PubMed
  61. Glatter K, Yang Y, Chatterjee K ym. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Circulation 2001;103:253-7 «PMID: 11208685»PubMed
  62. Go AS, Hylek EM, Chang Y ym. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003;290:2685-92 «PMID: 14645310»PubMed
  63. Goette A, Schön N, Kirchhof P ym. Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial. Circ Arrhythm Electrophysiol 2012;5:43-51 «PMID: 22157519»PubMed
  64. Granger CB, Alexander JH, McMurray JJ ym. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-92 «PMID: 21870978»PubMed
  65. Hart RG, Benavente O, McBride R ym. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501 «PMID: 10507957»PubMed
  66. Hart RG, Diener HC, Yang S ym. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke 2012;43:1511-7 «PMID: 22492518»PubMed
  67. Hauck M, Bauer A, Voss F ym. Effect of cardiac resynchronization therapy on conversion of persistent atrial fibrillation to sinus rhythm. Clin Res Cardiol 2009;98:189-94 «PMID: 19034378»PubMed
  68. Healey JS, Baranchuk A, Crystal E ym. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005;45:1832-9 «PMID: 15936615»PubMed
  69. Healey JS, Crystal E, Lamy A ym. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005;150:288-93 «PMID: 16086933»PubMed
  70. Hilleman DE, Spinler SA. Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. Pharmacotherapy 2002;22:66-74 «PMID: 11794432»PubMed
  71. Hohnloser SH, Crijns HJ, van Eickels M ym. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78 «PMID: 19213680»PubMed
  72. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000;356:1789-94 «PMID: 11117910»PubMed
  73. Holmes DR Jr, Doshi SK, Kar S ym. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. J Am Coll Cardiol 2015;65:2614-2623 «PMID: 26088300»PubMed
  74. Holmes DR Jr, Kar S, Price MJ ym. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014;64:1-12 «PMID: 24998121»PubMed
  75. Holmes DR, Reddy VY, Turi ZG ym. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42 «PMID: 19683639»PubMed
  76. Hongo RH, Themistoclakis S, Raviele A ym. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. J Am Coll Cardiol 2004;44:864-8 «PMID: 15312873»PubMed
  77. Huang W, Su L, Wu S ym. Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction. J Am Heart Assoc 2017;6: «PMID: 28365568»PubMed
  78. Huffman MD, Karmali KN, Berendsen MA ym. Concomitant atrial fibrillation surgery for people undergoing cardiac surgery. Cochrane Database Syst Rev 2016;:CD011814 «PMID: 27551927»PubMed
  79. Hylek EM, Evans-Molina C, Shea C ym. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007;115:2689-96 «PMID: 17515465»PubMed
  80. Hylek EM, Skates SJ, Sheehan MA ym. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-6 «PMID: 8678931»PubMed
  81. Jibrini MB, Molnar J, Arora RR. Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis. Am J Ther 2008;15:36-43 «PMID: 18223352»PubMed
  82. Johnson WD, Ganjoo AK, Stone CD ym. The left atrial appendage: our most lethal human attachment! Surgical implications. Eur J Cardiothorac Surg 2000;17:718-22 «PMID: 10856866»PubMed
  83. Kanderian AS, Gillinov AM, Pettersson GB ym. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol 2008;52:924-9 «PMID: 18772063»PubMed
  84. Katz ES, Tsiamtsiouris T, Applebaum RM ym. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol 2000;36:468-71 «PMID: 10933359»PubMed
  85. Kay GN, Ellenbogen KA, Giudici M ym. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998;2:121-35 «PMID: 9870004»PubMed
  86. Khan IA, Mehta NJ, Gowda RM. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol 2003;89:239-48 «PMID: 12767548»PubMed
  87. Khand AU, Rankin AC, Martin W ym. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol 2003;42:1944-51 «PMID: 14662257»PubMed
  88. Kiès P, Leclercq C, Bleeker GB ym. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 2006;92:490-4 «PMID: 16159986»PubMed
  89. Kistler PM, Sanders P, Morton JB ym. Effect of body mass index on defibrillation thresholds for internal cardioversion in patients with atrial fibrillation. Am J Cardiol 2004;94:370-2 «PMID: 15276109»PubMed
  90. Klein AL, Grimm RA, Murray RD ym. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-20 «PMID: 11346805»PubMed
  91. Klein AL, Murray RD, Becker ER ym. Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks. J Am Coll Cardiol 2004;43:1217-24 «PMID: 15063433»PubMed
  92. Ko D, Rahman F, Schnabel RB ym. Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol 2016;13:321-32 «PMID: 27053455»PubMed
  93. Kochiadakis GE, Igoumenidis NE, Simantirakis EN ym. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study. Pacing Clin Electrophysiol 1998;21:2475-9 «PMID: 9825370»PubMed
  94. Kochiadakis GE, Kanoupakis EM, Kalebubas MD ym. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study. Europace 2001;3:73-9 «PMID: 11271956»PubMed
  95. Kowey PR, Dorian P, Mitchell LB ym. Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009;2:652-9 «PMID: 19948506»PubMed
  96. Krijthe BP, Kunst A, Benjamin EJ ym. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013;34:2746-51 «PMID: 23900699»PubMed
  97. Kühlkamp V, Schirdewan A, Stangl K ym. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2000;36:139-46 «PMID: 10898425»PubMed
  98. Køber L, Torp-Pedersen C, McMurray JJ ym. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008;358:2678-87 «PMID: 18565860»PubMed
  99. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA ym. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 2007;:CD005049 «PMID: 17943835»PubMed
  100. Lamas GA, Lee KL, Sweeney MO ym. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854-62 «PMID: 12063369»PubMed
  101. Larsen TB, Skjøth F, Nielsen PB ym. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ 2016;353:i3189 «PMID: 27312796»PubMed
  102. Laupacis A, Albers G, Dalen J ym. Antithrombotic therapy in atrial fibrillation. Chest 1998;114:579S-589S «PMID: 9822064»PubMed
  103. Le Heuzey JY, De Ferrari GM, Radzik D ym. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol 2010;21:597-605 «PMID: 20384650»PubMed
  104. Lehto M ym. 2020, julkaisematon havainto. FINACAF rekisteri
  105. Lehto M, Niiranen J, Korhonen P ym. Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry. Pharmacoepidemiol Drug Saf 2017;26:657-665 «PMID: 28317274»PubMed
  106. Lewis RV, McMurray J, McDevitt DG. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. J Cardiovasc Pharmacol 1989;13:1-6 «PMID: 2468920»PubMed
  107. Lindholm CJ, Fredholm O, Möller SJ ym. Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil. Heart 2004;90:534-8 «PMID: 15084552»PubMed
  108. Madrid AH, Bueno MG, Rebollo JM ym. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002;106:331-6 «PMID: 12119249»PubMed
  109. Manning WJ, Silverman DI, Gordon SP ym. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993;328:750-5 «PMID: 8437595»PubMed
  110. McIntyre WF, Healey JS, Bhatnagar AK ym. Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis. Europace 2019;21:1159-1166 «PMID: 31292622»PubMed
  111. McNamara RL, Brass LM, Drozda JP Jr ym. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Commitee to Develop Data Standards on Atrial Fibrillation). J Am Coll Cardiol 2004;44:475-95 «PMID: 15261958»PubMed
  112. Morgan CL, McEwan P, Tukiendorf A ym. Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thromb Res 2009;124:37-41 «PMID: 19062079»PubMed
  113. Naccarelli GV, Dorian P, Hohnloser SH ym. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group. Am J Cardiol 1996;77:53A-59A «PMID: 8607392»PubMed
  114. Okumura K, Akao M, Yoshida T ym. Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. N Engl J Med 2020;383:1735-1745 «PMID: 32865374»PubMed
  115. Olesen JB, Lip GY, Hansen ML ym. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011;342:d124 «PMID: 21282258»PubMed
  116. Olsson SB, Executive Steering Committee of the SPORTIF III Investigators.. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet 2003;362:1691-8 «PMID: 14643116»PubMed
  117. Onalan O, Crystal E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke 2007;38:624-30 «PMID: 17261703»PubMed
  118. Oral H, Souza JJ, Michaud GF ym. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 1999;340:1849-54 «PMID: 10369847»PubMed
  119. Osmancik P, Herman D, Neuzil P ym. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. J Am Coll Cardiol 2020;75:3122-3135 «PMID: 32586585»PubMed
  120. Padeletti L, Pürerfellner H, Adler SW ym. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003;14:1189-95 «PMID: 14678133»PubMed
  121. Pappone C, Rosanio S, Augello G ym. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003;42:185-97 «PMID: 12875749»PubMed
  122. Patel MR, Mahaffey KW, Garg J ym. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91 «PMID: 21830957»PubMed
  123. Petersen P, Boysen G, Godtfredsen J ym. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989;1:175-9 «PMID: 2563096»PubMed
  124. Peuhkurinen K, Niemelä M, Ylitalo A ym. Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation. Am J Cardiol 2000;85:462-5 «PMID: 10728951»PubMed
  125. Piccini JP, Hasselblad V, Peterson ED ym. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 2009;54:1089-95 «PMID: 19744618»PubMed
  126. Piccini JP, Lopes RD, Kong MH ym. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009;2:626-33 «PMID: 20009077»PubMed
  127. Pietersen AH, Hellemann H. Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group. Am J Cardiol 1991;67:713-7 «PMID: 1900978»PubMed
  128. Platia EV, Michelson EL, Porterfield JK ym. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 1989;63:925-9 «PMID: 2564725»PubMed
  129. Plewan A, Lehmann G, Ndrepepa G ym. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Eur Heart J 2001;22:1504-10 «PMID: 11482924»PubMed
  130. Pollack CV Jr, Reilly PA, van Ryn J ym. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med 2017;377:431-441 «PMID: 28693366»PubMed
  131. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med 1992;116:6-12 «PMID: 1727097»PubMed
  132. Reisinger J, Gatterer E, Heinze G ym. Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. Am J Cardiol 1998;81:1450-4 «PMID: 9645896»PubMed
  133. Reisinger J, Gatterer E, Lang W ym. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur Heart J 2004;25:1318-24 «PMID: 15288159»PubMed
  134. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57 «PMID: 8018000»PubMed
  135. Roijer A, Eskilsson J, Olsson B. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Eur Heart J 2000;21:837-47 «PMID: 10781356»PubMed
  136. Roy D, Pratt CM, Torp-Pedersen C ym. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation 2008;117:1518-25 «PMID: 18332267»PubMed
  137. Roy D, Rowe BH, Stiell IG ym. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation. J Am Coll Cardiol 2004;44:2355-61 «PMID: 15607398»PubMed
  138. Roy D, Talajic M, Dorian P ym. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-20 «PMID: 10738049»PubMed
  139. Roy D, Talajic M, Nattel S ym. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008;358:2667-77 «PMID: 18565859»PubMed
  140. Ruff CT, Giugliano RP, Braunwald E ym. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014;383:955-62 «PMID: 24315724»PubMed
  141. Saarela E, Koskela V, Strandberg M ym. [Transesophageal echocardiography-guided cardioversion]. Duodecim 2004;120:1575-81 «PMID: 15326964»PubMed
  142. Saliba W, Gronich N, Barnett-Griness O ym. The role of CHADS2 and CHA2 DS2 -VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population-based study. J Thromb Haemost 2016;14:1155-62 «PMID: 27037960»PubMed
  143. Savelieva I, Camm J. Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation? Am Heart J 2007;154:403-6 «PMID: 17719281»PubMed
  144. Schneider MP, Hua TA, Böhm M ym. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. J Am Coll Cardiol 2010;55:2299-307 «PMID: 20488299»PubMed
  145. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993;342:1255-62 «PMID: 7901582»PubMed
  146. Segal JB, McNamara RL, Miller MR ym. The evidence regarding the drugs used for ventricular rate control. J Fam Pract 2000;49:47-59 «PMID: 10678340»PubMed
  147. Seto TB, Taira DA, Tsevat J ym. Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation. J Am Coll Cardiol 1997;29:122-30 «PMID: 8996304»PubMed
  148. Singh BN, Connolly SJ, Crijns HJ ym. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007;357:987-99 «PMID: 17804843»PubMed
  149. Singh J, Mela T, Ruskin J. Images in cardiovascular medicine. Sleep (vagal)-induced atrial fibrillation. Circulation 2004;110:e32-3 «PMID: 15277334»PubMed
  150. Singh S, Saini RK, DiMarco J ym. Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group. Am J Cardiol 1991;68:1227-30 «PMID: 1951086»PubMed
  151. Stambler BS, Wood MA, Ellenbogen KA ym. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation 1996;94:1613-21 «PMID: 8840852»PubMed
  152. Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Circulation 1997;96:4298-306 «PMID: 9416896»PubMed
  153. Stambler BS, Wood MA, Ellenbogen KA. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. Am J Cardiol 1996;77:960-6 «PMID: 8644646»PubMed
  154. Steeds RP, Birchall AS, Smith M ym. An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation. Heart 1999;82:170-5 «PMID: 10409530»PubMed
  155. Sung RJ, Tan HL, Karagounis L ym. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. Am Heart J 1995;129:739-48 «PMID: 7900626»PubMed
  156. Suttorp MJ, Kingma JH, Lie-A-Huen L ym. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 1989;63:693-6 «PMID: 2493733»PubMed
  157. Södermark T, Jonsson B, Olsson A ym. Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm. Br Heart J 1975;37:486-92 «PMID: 1093559»PubMed
  158. Testa L, Biondi-Zoccai GG, Dello Russo A ym. Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis. Eur Heart J 2005;26:2000-6 «PMID: 15872032»PubMed
  159. Tomasdottir M, Friberg L, Hijazi Z ym. Risk of ischemic stroke and utility of CHA2 DS2 -VASc score in women and men with atrial fibrillation. Clin Cardiol 2019;42:1003-1009 «PMID: 31490011»PubMed
  160. Touboul P, Brugada J, Capucci A ym. Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J 2003;24:1481-7 «PMID: 12919771»PubMed
  161. Tse HF, Lau CP, Wang Q ym. Effect of diltiazem on the recurrence rate of paroxysmal atrial fibrillation. Am J Cardiol 2001;88:568-70 «PMID: 11524073»PubMed
  162. Tse HF, Wang Q, Yu CM ym. Effect of verapamil on prevention of atrial fibrillation in patients implanted with an implantable atrial defibrillator. Clin Cardiol 2001;24:503-5 «PMID: 11450689»PubMed
  163. Turagam MK, Osmancik P, Neuzil P ym. Left Atrial Appendage Closure Versus Oral Anticoagulants in Atrial Fibrillation: A Meta-Analysis of Randomized Trials. J Am Coll Cardiol 2020;76:2795-2797 «PMID: 33272374»PubMed
  164. Tveit A, Seljeflot I, Grundvold I ym. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. Am J Cardiol 2007;99:1544-8 «PMID: 17531578»PubMed
  165. Van Gelder IC, Crijns HJ, Van Gilst WH ym. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-6 «PMID: 2058558»PubMed
  166. Van Gelder IC, Hagens VE, Bosker HA ym. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40 «PMID: 12466507»PubMed
  167. Van Noord T, Van Gelder IC, Tieleman RG ym. VERDICT: the Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2001;12:766-9 «PMID: 11469424»PubMed
  168. van Walraven C, Hart RG, Singer DE ym. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002;288:2441-8 «PMID: 12435257»PubMed
  169. Weber S, Ndrepepa G, Schneider M ym. Two-to-one conduction block between left atrium and right lower pulmonary vein preceding complete vein isolation during radiofrequency current ablation. Pacing Clin Electrophysiol 2004;27:829-30 «PMID: 15189546»PubMed
  170. Weigner MJ, Thomas LR, Patel U ym. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year. Am J Med 2001;110:694-702 «PMID: 11403753»PubMed
  171. Weiner P, Ganam R, Ganem R ym. Clinical course of recent-onset atrial fibrillation treated with oral propafenone. Chest 1994;105:1013-6 «PMID: 8162718»PubMed
  172. White HD, Gruber M, Feyzi J ym. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 2007;167:239-45 «PMID: 17296878»PubMed
  173. Vitolo E, Tronci M, Larovere MT ym. Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. Acta Cardiol 1981;36:431-44 «PMID: 7039195»PubMed
  174. Volgman AS, Carberry PA, Stambler B ym. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998;31:1414-9 «PMID: 9581743»PubMed
  175. Wood MA, Brown-Mahoney C, Kay GN ym. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. Circulation 2000;101:1138-44 «PMID: 10715260»PubMed
  176. Vos MA, Golitsyn SR, Stangl K ym. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart 1998;79:568-75 «PMID: 10078083»PubMed
  177. Wu VC, Wu M, Aboyans V ym. Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation. Heart 2020;106:534-540 «PMID: 31558571»PubMed
  178. Wyse DG, Waldo AL, DiMarco JP ym. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33 «PMID: 12466506»PubMed
  179. Zarembski DG, Nolan PE Jr, Slack MK ym. Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide. Arch Intern Med 1995;155:1885-91 «PMID: 7677555»PubMed
Artikkelin tunnus: nix02895 (050.036)
© 2023 Suomalainen Lääkäriseura Duodecim

Käypä hoito -suositus

Anna palautetta
Linkkien värikoodit